Autopsy report · NCT03637868

Eribulin in Brain Metastases From HER2-negative Breast Cancer

“no enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Institut Paoli-Calmettes

Sponsor type

University, hospital or other

Conditions

Metastatic Breast Cancer

Interventions

Eribulin

Participants

0

Sites

7

Countries

France

Trials that died the same way

• Intraosseous Basivertebral Nerve Ablation for Treatment of Chronic Low Back Pain
  “No Enrollments” (96% match in meaning)
• The "Peripheral Access Utilizing Sonographic Evaluation" Study
  “No enrollment was achieved” (87% match in meaning)
• Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants
  “Not sufficient enrollment” (83% match in meaning)
• DC Vaccine in Colorectal Cancer
  “Lack of enrollment” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.